Patients with CKD who use antiresorptive drugs for tumor-related disorders or oral corticosteroids may be at increased risk for osteonecrosis of the jaw.

Increased postoperative opioid consumption was associated with higher probability of new persistent opioid use in opioid-naive patients.

Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes. (HealthDay News) — For patients with overweight or obesity and type 2 diabetes ...

Findings independent of age, pregnancy, and menopausal status. (HealthDay News) — Women have a higher risk for developing long COVID than men, according to a study published online in JAMA ...

Rates of both MCI and composite of MCI or probable dementia lower with intensive treatment in extended follow-up study ...

No significant associations seen for SLE or AS with prostate cancer or in reverse MR analyses. (HealthDay News) — Genetically predicted rheumatoid arthritis (RA) is causally associated with ...

(HealthDay News) — Time-restricted eating (TRE) may not add additional benefit in visceral adipose tissue reduction over the Mediterranean diet for people with overweight or obesity, according to a ...

A growing body of evidence links use of proton pump inhibitors to kidney problems, including kidney failure in patients with existing CKD.

A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application ...